We describe a general application of the nonsense suppression methodology for unnatural amino acid incorporation to probe drugreceptor interactions in functional G protein-coupled receptors (GPCRs), evaluating the binding sites of both the M2 muscarinic acetylcholine receptor and the D2 dopamine receptor. Receptors were expressed in Xenopus oocytes, and activation of a G protein-coupled, inward-rectifying K ؉ channel (GIRK) provided, after optimization of conditions, a quantitative readout of receptor function. A number of aromatic amino acids thought to be near the agonist-binding site were evaluated. Incorporation of a series of fluorinated tryptophan derivatives at W6.48 of the D2 receptor establishes a cation-interaction between the agonist dopamine and W6.48, suggesting a reorientation of W6.48 on agonist binding, consistent with proposed ''rotamer switch'' models. Interestingly, no comparable cationinteraction was found at the aligning residue in the M2 receptor.D2 receptor ͉ fluorination ͉ membrane protein G protein-coupled receptors (GPCRs) represent the largest family of transmembrane receptor proteins in the human genome and constitute a prominent class of targets for the pharmaceutical industry (1-3). Accordingly, they have been studied extensively throughout academia and industry, by using the full range of chemical, biochemical, and biophysical techniques. In recent years, the field has been energized by several high-resolution crystal structures of mammalian GPCRs that build upon the earlier, highly informative structural studies of rhodopsin and bacteriorhodopsin (4-9).The structural snapshots provided by crystallography greatly enhance our understanding of specific receptors but also raise many new issues. Key among these is the extent to which the information from available structures can be extrapolated to the hundreds of other GPCRs. In addition, a key goal in the study of GPCRs-and all receptors-is a description of the interconversions among several structural states that underlie the protein's biological function. It can be a challenging task to deduce a signaling mechanism from static images. As such, structure-function studies, guided by the new structural advances, will remain an important tool in evaluating GPCR function and the nature of drug-receptor interactions in this family.In recent years, unnatural amino acid mutagenesis on ion channels and receptors expressed in Xenopus oocytes has provided a powerful tool for uncovering crucial drug-receptor interactions and signaling mechanisms (10, 11). GPCRs present an especially attractive target for unnatural amino acid mutagenesis, given the importance of the family, the significant pharmacological variations among closely related family members, and the central role of structural rearrangements in their biological function.Incorporating unnatural amino acids into GPCRs, however, presents unique challenges. Most unnatural amino acid mutagenesis studies in eukaryotic cells have focused on ion channels. These studies exploit the exquisite s...